Dr. Manoj Monga, MD

Dr. Monga practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Monga's NPI, 1174609127, was assigned on October 31, 2006. Dr. Monga graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Monga holds California license G81273.

Dr. Monga's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Monga's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Monga is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Monga practices. Vendor and product names are available with a free account.

Urology is Dr. Monga's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Monga is board certified in urology by the American Board of Urology. Dmand AI has Dr. Monga's licenses on file in 4 states: California, Ohio, Minnesota and Louisiana.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney stone disease, prostate cancer, urinary endoscopy and urine flow blockage among the conditions Dr. Monga treats.

CMS data shows 211 Medicare services from Dr. Monga across 7 procedure codes in 2024, for 160 Medicare patients. Medicare paid $21,795 for them.

CMS counts 160 Medicare patients who saw Dr. Monga in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Monga's median patient age at 61, with 38% women.

In 2024, Dr. Monga wrote 477 Medicare Part D claims for 147 patients. 95% of them were for generic drugs. CMS names the drug for 400 of them, across 12 drugs with 11 or more claims each, at $32,601 in total drug cost. In 2023, CMS named 282 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Monga for performance year 2024, reported as part of a group. Dr. Monga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Monga as offering telehealth.

Dmand AI links 284 papers to Dr. Monga, published from 2006 to 2025. 2018 was the busiest year, with 10. The most frequent topics are Kidney Calculi, Ureteroscopy and Equipment Design. Dr. Monga has published most often in J Endourol. Dr. Monga's most frequent co-authors are Benjamin Kirk Canales, MD, Bryan D. Hinck, MD and James Kyle Anderson, MD.

Dmand AI links Dr. Monga to 8 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Ureteral Calculi, Ureterolithiasis and Colic. The Cleveland Clinic sponsors the most, 4.

CMS Open Payments shows 230 general payments to Dr. Monga from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Boston Scientific Corporation paid the most, $51,485. It also lists 2 research payments totaling $899 in 2020.

Dmand AI lists 38 awards for Dr. Monga, most recently Honorary Member in 2015.

Dr. Monga graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Monga is a member of ACS.

Dr. Monga is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.